Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome.

@article{Cattelan1999RegressionOA,
  title={Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome.},
  author={Anna Maria Cattelan and Maria Luisa Calabr{\'o} and Savina Maria Luciana Aversa and Marisa Zanchetta and Francesco Meneghetti and Anita De Rossi and Luigi Chieco-Bianchi},
  journal={European journal of cancer},
  year={1999},
  volume={35 13},
  pages={1809-15}
}
The clinical response of AIDS-related Kaposi's sarcoma (KS) to highly active antiretroviral therapy (HAART), a combination of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase inhibitors, was studied in 11 patients, all but one with progressive KS. CD4+ cell counts, plasma HIV-1 RNA levels, and antibody titres to lytic ORF65 and latency-associated human herpes virus type 8 (HHV-8) proteins were determined in sequential samples. Six complete and three partial… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Kaposi's sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis

  • D Whitby, C. BoshoV
  • Curr Opin Oncol 1998,
  • 1998
1 Excerpt

Similar Papers

Loading similar papers…